Acutely Psychotic Patients With Schizophrenia clinical trials

Explore recruiting acutely psychotic patients with schizophrenia clinical trials.

Recruiting acutely psychotic patients with schizophrenia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acutely Psychotic Patients With Schizophrenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Patients with Schizophrenia, Followed by an Open-label Extension Phase

Romania

Phase II and Phase III (Integrated) EU CTIS Study details

Acutely Psychotic Patients With Schizophrenia trials by city

Acutely Psychotic Patients With Schizophrenia in Toronto Acutely Psychotic Patients With Schizophrenia in Vancouver Acutely Psychotic Patients With Schizophrenia in Montreal Acutely Psychotic Patients With Schizophrenia in Calgary Acutely Psychotic Patients With Schizophrenia in Edmonton Acutely Psychotic Patients With Schizophrenia in Ottawa Acutely Psychotic Patients With Schizophrenia in Winnipeg Acutely Psychotic Patients With Schizophrenia in Quebec City Acutely Psychotic Patients With Schizophrenia in Hamilton Acutely Psychotic Patients With Schizophrenia in Kitchener Acutely Psychotic Patients With Schizophrenia in London Acutely Psychotic Patients With Schizophrenia in Halifax Acutely Psychotic Patients With Schizophrenia in New York Acutely Psychotic Patients With Schizophrenia in Los Angeles Acutely Psychotic Patients With Schizophrenia in Chicago Acutely Psychotic Patients With Schizophrenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease